10.1016/S0764-4469(00)87189-9
Arnon R., 1989, Suppression of experimental allergic encephalomyelitis by COP1‐‐relevance to multiple sclerosis., Isr. J. Med. Sci., 25, 686
10.1016/0165-2478(96)02506-0
Filippi M., 2001, Glatiramer acetate reduces the proportion of new MS lesions evolving into “black holes”., Neurology, 57, 731, 10.1212/WNL.57.4.731
10.1517/14656566.2.7.1149
Teitelbaum D., 1997, Copolymer 1 from the laboratory to FDA., Isr. J. Med. Sci., 33, 280
10.1016/S0165-5728(02)00053-X
10.4049/jimmunol.179.7.4345
10.1016/S1471-4914(02)02373-0
10.1089/089771503767168483
10.4049/jimmunol.171.12.6549
10.1111/j.1471-4159.2004.02954.x
10.1046/j.1471-4159.1999.0720102.x
10.1016/j.biopsych.2005.06.036
10.1046/j.0022-3042.2001.00752.x
10.1046/j.1471-4159.1997.68020564.x
10.1002/(SICI)1097-0029(19990515/01)45:4/5<276::AID-JEMT11>3.0.CO;2-4
von Bartheld C. S., 1998, Neurotrophins in the developing and regenerating visual system., Histol. Histopathol., 13, 437
10.1016/S0197-0186(96)00071-X
10.1002/(SICI)1097-0029(19991001)47:1<3::AID-JEMT2>3.0.CO;2-2
10.3109/13550289909021287
10.1016/S0002-9440(10)65476-4
10.1002/1521-4141(200207)32:7<2074::AID-IMMU2074>3.0.CO;2-S
10.4049/jimmunol.174.6.3394
10.1007/s11060-004-3339-x
10.1016/j.vaccine.2005.12.056
10.1111/j.0022-202X.2004.23318.x
10.4049/jimmunol.172.10.6281
10.1016/S0165-5728(98)00166-0
10.2174/156720105774370258
10.1523/JNEUROSCI.1859-05.2005
10.1007/s00109-005-0689-6
10.1111/j.1365-2249.2006.02997.x
10.1191/1352458504ms979oa
10.1016/S1474-4422(05)70167-8
10.1016/j.jneuroim.2003.11.014
Cao M. D., 2003, Modulation effects of human immature and mature dendritic cells on glatiramer acetate specific T cell lines in vitro., Zhongguo Shi Yan Xue Ye Xue Za Zhi, 11, 409
10.4049/jimmunol.178.1.520
Haugland R. P., 1995, Coupling of monoclonal antibodies with fluorophores., Methods Mol. Biol, 45, 205
10.1182/blood-2005-11-4721